# Pharvaris (PHVS) — Earnings

PHVS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/phvs/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$0.70 |
| EPS estimate | −$0.76 |
| EPS surprise | +7.17% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1830487/000119312525276005/6-k_q3_25.htm) |

Pharvaris reported Q3 2025 results on November 12, 2025. The company posted a loss of $0.70 per share, narrower than the $0.76 loss analysts expected, a 7.17% beat. A year earlier, in Q3 2024, the loss was $0.86 per share. The table shows no revenue for Pharvaris and no revenue estimates in any quarter.

Every quarter in the table is a loss. Quarterly losses have mostly ranged between about $0.55 and $1.00 per share, with the widest at $1.24 in Q4 2022 and the narrowest at $0.40 in Q2 2022. Full-year losses were $2.78 per share in 2023 and $2.67 in 2024. The first three quarters of 2025 add up to a loss of $2.60, compared with $2.01 for the same period of 2024. The record has gaps: Q4 2021 and Q3 2022 are missing. Against estimates the results are evenly split, with seven beats, eight misses and one match across the 16 quarters shown.

Pharvaris has reported fourth-quarter results in early April and second-quarter results in August, but the table holds no report after November 2025. The next figures added will show whether losses per share stay near the 2024 and 2025 range.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 12, 2025 | −$0.76 | −$0.70 | 7.17% | — | — |
| Q2 2025 | Aug 12, 2025 | −$0.90 | −$0.98 | -8.30% | — | — |
| Q1 2025 | May 13, 2025 | −$0.83 | −$0.92 | -10.65% | — | — |
| Q4 2024 | Apr 7, 2025 | −$0.75 | −$0.66 | 11.54% | — | — |
| Q3 2024 | Nov 13, 2024 | −$0.66 | −$0.86 | -30.05% | — | — |
| Q2 2024 | Aug 14, 2024 | −$0.59 | −$0.59 | 0.32% | — | — |
| Q1 2024 | May 8, 2024 | −$0.61 | −$0.56 | 7.65% | — | — |
| Q4 2023 | Apr 10, 2024 | −$0.59 | −$0.82 | -38.82% | — | — |
| Q3 2023 | Nov 2, 2023 | −$0.64 | −$0.61 | 3.93% | — | — |
| Q2 2023 | Aug 7, 2023 | −$0.67 | −$0.69 | -3.03% | — | — |
| Q1 2023 | May 8, 2023 | −$0.80 | −$0.66 | 17.89% | — | — |
| Q4 2022 | Apr 5, 2023 | −$0.70 | −$1.24 | -77.87% | — | — |
| Q2 2022 | Sep 12, 2022 | −$0.59 | −$0.40 | 32.97% | — | — |
| Q1 2022 | May 11, 2022 | −$0.52 | −$0.53 | -1.59% | — | — |
| Q3 2021 | Nov 10, 2021 | −$0.56 | −$0.45 | 19.59% | — | — |
| Q2 2021 | Jul 30, 2021 | −$0.52 | −$1.11 | -114.86% | — | — |

## Frequently Asked Questions

### When did Pharvaris (PHVS) last report earnings?

Pharvaris last reported on Nov 12, 2025, covering fiscal Q3 2025.

### Did PHVS beat earnings estimates?

Yes. Pharvaris reported EPS of −$0.70 for Q3 2025 against a −$0.76 estimate — a 7.17% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).